A research team has developed a causal deep learning model to personalize corticosteroid therapy for intensive care unit ...

Sepsis is the body’s extreme reaction to an infection. It causes 11 million deaths annually and is a global health priority affecting 55 million patients worldwide annually. Treatment for sepsis ...

USA: Researchers have found in a randomized trial that among adults with septic shock, the beta-blocker esmolol showed ...

Of all the life-threatening conditions hospitals battle on a daily basis, sepsis is a particularly fickle beast. Despite the difficulties associated with diagnosing this complication, healthcare ...

Craig Lilly, MD, a pulmonary medicine and critical care specialist at the University of Massachusetts Memorial Medical Center, who was not one of the trial results authors, reacted to the study. "This ...

Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...

Inotrem and Roche’s diagnostics division have upgraded their years-long collaboration on a plasma test for septic shock, with a new worldwide licensing agreement. The France-based Inotrem secured the ...

According to the Centers for Disease Control and Prevention, there are more than 1.7 million cases of sepsis every year, leading to 300,000 annual deaths. "Sepsis is a potentially lethal condition; ...

SYDNEY--(BUSINESS WIRE)--Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announced an international patent application aimed at protecting the use of experimental ...

A Winnipeg sepsis survivor says he wants to see Manitoba follow Nova Scotia's lead and change how it treats the condition ...

A combination of vitamin C, thiamine and hydrocortisone, previously thought to be a promising treatment option for sepsis, did not improve patient outcomes in a study recently published in JAMA. It’s ...